PET with 18F-FDG and 18F-FMAU in the assessment of early response to EGFR-targeted therapy in mice bearing human NSCLC xenografts with different EGFR mutations

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.